Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryoport (CYRX) Research & Development (2016 - 2025)

Historic Research & Development for Cryoport (CYRX) over the last 17 years, with Q3 2025 value amounting to $4.5 million.

  • Cryoport's Research & Development rose 880.44% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.7 million, marking a year-over-year decrease of 859.92%. This contributed to the annual value of $17.7 million for FY2024, which is 182.93% down from last year.
  • According to the latest figures from Q3 2025, Cryoport's Research & Development is $4.5 million, which was up 880.44% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Cryoport's Research & Development registered a high of $5.2 million during Q3 2023, and its lowest value of $3.5 million during Q2 2022.
  • In the last 5 years, Cryoport's Research & Development had a median value of $4.2 million in 2021 and averaged $4.3 million.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 14835.55% in 2021, then plummeted by 2106.68% in 2022.
  • Over the past 5 years, Cryoport's Research & Development (Quarter) stood at $3.9 million in 2021, then grew by 20.23% to $4.7 million in 2022, then increased by 1.54% to $4.7 million in 2023, then dropped by 12.51% to $4.2 million in 2024, then increased by 8.86% to $4.5 million in 2025.
  • Its Research & Development was $4.5 million in Q3 2025, compared to $4.1 million in Q2 2025 and $3.9 million in Q1 2025.